Kerry Wentworth, VP, Clin, Reg & Quality at ANTIGENICS INC /DE/ (AGEN), sold 4,165 shares at $1.21 ($5K) on 2010-04-26, disclosed to the SEC on 2010-04-28.
Scheduled sale ($5k) by VP, Clin, Reg & Quality under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NUVB | SELL | 2026-04-08 | $904K | — | Filing → |
| NUVB | BUY | 2025-06-18 | $90K | — | Filing → |
| FLXN | SELL | 2021-07-20 | $25K | — | Filing → |